Although increased level of IL-17 was detected in intestinal mucosa of patients with Crohn's disease and ulcerative colitis, IL-17 might be a predictor or protective factor for intestinal inflammation rather than therapeutic target due to the ineffectiveness in clinical trials of Crohn's disease (31, 32). Here, IL17A is linked to Crohn disease.